Literature DB >> 8842408

Reproductive experience increases striatal and hypothalamic dopamine levels in pregnant rats.

L F Felicio1, J C Florio, L H Sider, P E Cruz-Casallas, R S Bridges.   

Abstract

The effects of parity on the dopaminergic function of rats were studied. Striatal and hypothalamic levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), norepinephrine (NE), serotonin (5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) as well as serum prolactin (PRL) levels of 7-days primigravid and multigravid rats were compared. Brains and trunk blood were collected from 1200-1400 h on day 7 of pregnancy and assayed for monoamines and their metabolites, and prolactin, respectively. Multigravid rats showed a significant increase in striatal and hypothalamic dopamine levels. A tendency to increase in striatal DOPAC levels was also observed in multigravid rats. Levels of other neuro-transmitters and metabolites were not statistically different. Haloperidol (1 mg/kg) treatment induced a significant increase in multigravid 5-HT striatal levels. There was no statistical difference among primigravid and multigravid serum PRL levels after either saline or haloperidol treatment. These data suggest that prior parity produces a shift in dopaminergic activity in multigravid rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842408     DOI: 10.1016/0361-9230(96)00008-1

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

1.  Prior parity positively regulates learning and memory in young and middle-aged rats.

Authors:  Erica Zimberknopf; Gilberto F Xavier; Craig H Kinsley; Luciano F Felicio
Journal:  Comp Med       Date:  2011-08       Impact factor: 0.982

2.  Plasticity of opioid receptors in the female periaqueductal gray: multiparity-induced increase in the activity of genes encoding for mu and kappa receptors and a post-translational decrease in delta receptor expression.

Authors:  Elizabeth Teodorov; Maria M Bernardi; Merari F R Ferrari; Debora R Fior-Chadi; Luciano F Felicio
Journal:  J Mol Neurosci       Date:  2010-06-24       Impact factor: 3.444

Review 3.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

4.  Parity and estrogen-administration alter affective behavior of ovariectomized rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Physiol Behav       Date:  2007-09-25

5.  Amphetamine sensitization in reproductively experienced female rats.

Authors:  John J Byrnes; Robert S Bridges; Elizabeth M Byrnes
Journal:  Neurosci Lett       Date:  2011-07-30       Impact factor: 3.046

Review 6.  The birth of new neurons in the maternal brain: Hormonal regulation and functional implications.

Authors:  Benedetta Leuner; Sara Sabihi
Journal:  Front Neuroendocrinol       Date:  2016-03-09       Impact factor: 8.606

Review 7.  Long-term alterations in neural and endocrine processes induced by motherhood in mammals.

Authors:  Robert S Bridges
Journal:  Horm Behav       Date:  2015-09-24       Impact factor: 3.587

8.  Differential expression of oestrogen receptor alpha following reproductive experience in young and middle-aged female rats.

Authors:  E M Byrnes; J A Babb; R S Bridges
Journal:  J Neuroendocrinol       Date:  2009-06       Impact factor: 3.627

9.  Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment.

Authors:  Celso A R A Costa; Thaís C Cury; Bruna O Cassettari; Regina K Takahira; Jorge C Flório; Mirtes Costa
Journal:  BMC Complement Altern Med       Date:  2013-02-23       Impact factor: 3.659

10.  Alstonine as an antipsychotic: effects on brain amines and metabolic changes.

Authors:  Viviane M Linck; Ana P Herrmann; Angelo L Piato; Bernardo C Detanico; Micheli Figueiró; Jorge Flório; Maurice M Iwu; Christopher O Okunji; Mirna B Leal; Elaine Elisabetsky
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.